Astragaloside IV and Ferulic Acid Loaded iRGD ‐Modified Liposomes Promote Diabetic Wound Healing by Suppressing H4K12 Lactylation‐Mediated FOXO1 Transcriptional Activation
Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2026-10 · 114 (10)
DOI: 10.1002/jbm.b.70174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, online erschienen am 26.10.2026. Verfasst von Xi Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hunan University of Chinese Medicine, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Triterpenes, Coumaric Acids, Wound Healing, Diabetes Mellitus, Experimental. Die Arbeit nennt 63 Literaturangaben. Gefördert von: Key Program of the Joint Fund for Natural Science Foundation of Hunan Province, The Science and Technology Innovation Program of Hunan Province, National Natural Science Foundation of China.
Themen: Wundversorgung
Abstract (Originalsprache)
Impaired wound healing is a severe complication of diabetes and is partly attributable to endothelial progenitor cell (EPC) dysfunction. Although liposomal delivery has attracted increasing interest in diabetic wound therapy, EPC‐targeted delivery strategies remain insufficiently defined. In this study, internalizing RGD (iRGD)‐modified liposomes co‐loaded with astragaloside IV and ferulic acid (Lp‐iRGD@AS‐IV/FA) were prepared by thin‐film hydration. Lp‐iRGD@AS‐IV/FA showed favorable sustained‐release behavior and enhanced uptake by EPCs. In a diabetic mouse wound model induced by a high‐fat diet and streptozotocin, Lp‐iRGD@AS‐IV/FA accelerated wound closure, improved epithelial architecture, reduced inflammatory infiltration, and increased collagen deposition. In bone marrow‐derived EPCs exposed to high glucose, Lp‐iRGD@AS‐IV/FA restored proliferation, migration, and tube formation, reduced lactate accumulation and histone lactylation, and alleviated mitochondrial dysfunction. Mechanistically, inhibition of lactate production by Oxamate decreased histone H4 lysine 12 lactylation (H4K12 la) and Forkhead Box O1 (FOXO1) expression, reduced H4K12la enrichment at the FOXO1 promoter, and suppressed FOXO1 promoter activity. Conversely, FOXO1 overexpression attenuated the protective effects of Lp‐iRGD@AS‐IV/FA on EPC function. These findings indicate that Lp‐iRGD@AS‐IV/FA promotes diabetic wound healing by suppressing H4K12la‐mediated FOXO1 transcriptional activation and support EPC‐targeted nanodelivery as a potential therapeutic strategy for diabetic wound repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hunan University of Chinese Medicine, Changsha, Hunan, China.
- Scientific Research and Teaching Department, Second People's Hospital of Hunan Province, Changsha, Hunan, China.
- Department of Plastic and Cosmetic Dermatology, Second People's Hospital of Hunan Province, Changsha, Hunan, China.
- The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Förderung
- Key Program of the Joint Fund for Natural Science Foundation of Hunan Province
- The Science and Technology Innovation Program of Hunan Province
- National Natural Science Foundation of China
- Medical and Health Joint Project of Hunan Natural Science Foundation
- University-Hospital Joint Foundation Project of Hunan University of Chinese Medicine
- Natural Science Foundation Project of Changsha
Zitieren
APA
Zhang, X., Guo, D., Zeng, C., Zou, X., Wei, J., Zhang, Z., Li, Q., Long, L., Wang, S., Xue, B., Ouyang, J., & Xiong, W. (2026). Astragaloside IV and Ferulic Acid Loaded iRGD ‐Modified Liposomes Promote Diabetic Wound Healing by Suppressing H4K12 Lactylation‐Mediated FOXO1 Transcriptional Activation. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 114(10). https://doi.org/10.1002/jbm.b.70174
Vancouver
Zhang X, Guo D, Zeng C, Zou X, Wei J, Zhang Z, et al. Astragaloside IV and Ferulic Acid Loaded iRGD ‐Modified Liposomes Promote Diabetic Wound Healing by Suppressing H4K12 Lactylation‐Mediated FOXO1 Transcriptional Activation. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2026;114(10). doi:10.1002/jbm.b.70174
BibTeX
@article{Zhang2026,
author = {Zhang, Xi and Guo, Dongwei and Zeng, Churuo and Zou, Xiaoling and Wei, Jieru and Zhang, Zihao and Li, Qinxia and Long, Liuya and Wang, Siyin and Xue, Bingqian and Ouyang, Jie and Xiong, Wu},
title = {Astragaloside IV and Ferulic Acid Loaded iRGD ‐Modified Liposomes Promote Diabetic Wound Healing by Suppressing H4K12 Lactylation‐Mediated FOXO1 Transcriptional Activation},
journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
year = {2026},
volume = {114},
number = {10},
doi = {10.1002/jbm.b.70174}
}
EUVIMED